AbridgePRIVATE · FOUNDED 2018Each bar is the last disclosed mark — $5.3B for Abridge (post-money, Apr 2026) and $2.25B for HistoSonics (basis undisclosed, Aug 2025).

AbridgePRIVATEHealth · US · 2018
The $5.3B tells you…At least one valuation basis is undisclosed, so the two numbers stay side by side, each with its own chip, and no ratio is scored. Both are private: there is no public quote and no Canborsa market on either name.
Abridge operates in Healthcare technology and AI (AI-powered clinical documentation), and HistoSonics operates in Medical Device.
Abridge is valued at $5.3B, and HistoSonics at $2.2B.
Abridge's headquarters is in Pittsburgh, Pennsylvania; HistoSonics's is in Plymouth, Minnesota.
Abridge is based in United States; HistoSonics is based in United States.